Global Central Nervous System (CNS) Therapeutic Market Report, 2024: A Projected $215.19 Billion Opportunity by 2034 with with Asia-Pacific Gaining Momentum
27 juin 2024 09h57 HE
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Central Nervous System Therapeutic Market" report has been added to ResearchAndMarkets.com's offering. The central nervous system (CNS)...
Multiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon Research
25 avr. 2024 08h50 HE
|
DataHorizzon Research
Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis. Multiple sclerosis (MS) is a condition characterized...
Multiple Sclerosis Market is estimated to be US$ 32.9 billion by 2032; Rising Early Diagnosis and Advancements in Treatment to Boost Market Growth – BY PMI
25 oct. 2023 14h00 HE
|
PMI
Covina, Oct. 25, 2023 (GLOBE NEWSWIRE) -- What is multiple sclerosis, and how does it affect patients? Multiple Sclerosis is often categorized into different clinical forms. The most common...
Multiple Sclerosis (MS) Market to Cross USD 28.21 Billion by 2030 due to Rising Prevalence of Multiple Sclerosis (MS) and Favorable Reimbursement Policies | Research by SNS Insider
10 mai 2023 09h15 HE
|
SNS Insider pvt ltd
Pune, May 10, 2023 (GLOBE NEWSWIRE) -- “The Multiple Sclerosis (MS) Market was valued at USD 23.2 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 2.2% over the...
Global Neurological Biomarkers Market Report 2022 to 2028: Featuring Bio-Rad Laboratories, Merck, PerkinElmer and Shimadzu Among Others
21 mars 2023 11h33 HE
|
Research and Markets
Dublin, March 21, 2023 (GLOBE NEWSWIRE) -- The "Global Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report by Type (Proteomic, Genomic, Metabolomic), Application...
Multiple Sclerosis Treatment Market Size to Surpass USD 30.55 Billion by 2030 at 2.31% CAGR – Report by Market Research Future (MRFR)
15 févr. 2023 09h00 HE
|
Market Research Future
New York, USA, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Multiple Sclerosis Treatment Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Multiple Sclerosis...
Multiple Sclerosis Global Market Analysis: Historical Data 2016-2020 and Forecasts for 2021-2026
25 févr. 2022 04h03 HE
|
Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Market - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights,...
Global Multiple Sclerosis Industry Review 2018-2020 with Forecasts to 2026 - Market Size by Country, Competitor Drug Sales, Market Shares, and More
24 déc. 2021 06h58 HE
|
Research and Markets
Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This report provides...
Global Multiple Sclerosis Drugs Market Report 2021: Market is Expected to Reach $25.95 Billion in 2025 - Long-term Forecast to 2030
13 déc. 2021 06h53 HE
|
Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Multiple Sclerosis Drugs Market Worth $40.66 Bn at 7.1% CAGR; Industry Bigwigs Such as Novartis and Biogen to Focus on Introducing Cost-Effective MS Treatments: Fortune Business Insights™
24 août 2020 07h56 HE
|
Fortune Business Insights
Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. ...